Understanding Barriers to Timely Diagnosis and Intervention Among Immigrant Children With Hearing Loss
Otolaryngology–Head and Neck Surgery · 2023-09 · 169 (3) · 701-709
DOI: 10.1002/ohn.322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 16.03.2023. Verfasst von Katrin Jaradeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Hearing Loss, Deafness, Emigrants and Immigrants. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Identify the age at diagnosis and intervention of immigrant and/or non‐English‐speaking children with hearing loss (HL) and risk factors associated with delays. Identify barriers for non‐English‐speaking caregivers of deaf/hard‐of‐hearing children. Study Design Sequential mixed methods.
Setting
Tertiary care center in an urban city.
Methods
The analysis includes descriptive statistics, and 1‐way and 2‐way analysis of variance of the retrospective chart review. The quantitative study demonstrated foreign‐born experienced disparities, so we conducted semistructured interviews on a subset of non‐English‐speaking families in the cohort that was then thematically analyzed using a human‐centered design strategy.
Results
We divided 532 children into 3 groups: US‐born with English as the preferred language (N = 294), US‐born and non‐English language preferred (N = 173), and foreign‐born (N = 67). The laterality of HL and pure‐tone averages were similar among the groups ( p = .972 and .071, respectively). Age at diagnosis and time to the intervention were significantly different (39.7, 31.5, 75.8 months, p < .001 and 24.6, 29.2, 48.9 months, p = .001, respectively). Ages at diagnosis and intervention were associated with birthplace ( p = .005, p = .0005, respectively) but not preferred language ( p = .667, p = .343, respectively). Included in the qualitative interviews were Mandarin‐ (n = 5), Arabic‐ (n = 4), and Spanish‐speaking families (n = 3). Insights revealed participants' quest for anticipatory guidance and social support, the consequences of cultural stigma, and the complexity of caring for a child with HL in an immigrant family.
Conclusion
Foreign‐born children with HL have significant delays in diagnosis and intervention compared to US‐born children. For non‐English‐speaking parents, the diagnosis of HL presents challenges beyond that of the immigrant experience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
- Department of General Surgery, University of California, San Francisco, California, USA.
- Department of Pediatrics, University of California, San Francisco, California, USA.
ORCID-Profile: Katrin Jaradeh, Lara Z Chehab, Kathleen P Tebb
Zitieren
APA
Jaradeh, K., Liao, E. N., Chehab, L. Z., Tebb, K. P., Florentine, M. M., Bellfort-Salinas, S., & Chan, D. K. (2023). Understanding Barriers to Timely Diagnosis and Intervention Among Immigrant Children With Hearing Loss. Otolaryngology–Head and Neck Surgery, 169(3), 701-709. https://doi.org/10.1002/ohn.322
Vancouver
Jaradeh K, Liao EN, Chehab LZ, Tebb KP, Florentine MM, Bellfort-Salinas S, et al. Understanding Barriers to Timely Diagnosis and Intervention Among Immigrant Children With Hearing Loss. Otolaryngology–Head and Neck Surgery. 2023;169(3):701-709. doi:10.1002/ohn.322
BibTeX
@article{Jaradeh2023,
author = {Jaradeh, Katrin and Liao, Elizabeth N and Chehab, Lara Z and Tebb, Kathleen P and Florentine, Michelle M and Bellfort-Salinas, Silvia and Chan, Dylan K},
title = {Understanding Barriers to Timely Diagnosis and Intervention Among Immigrant Children With Hearing Loss},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
volume = {169},
number = {3},
pages = {701--709},
doi = {10.1002/ohn.322}
}
EUVIMED